Isoniazid and Sprycel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Isoniazid (isoniazid) and Sprycel (dasatinib). Common drug interactions include headache among females and malaise among males.
The phase IV clinical study analyzes what interactions people have when they take Isoniazid and Sprycel. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Isoniazid?
Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.
What is Sprycel?
Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.
13 people who take Isoniazid and Sprycel together, and have interactions are studied.

What are the common drug interactions of Isoniazid and Sprycel, by gender? *:
female:
- Headache (pain in head)
- Anaemia (lack of blood)
- Interstitial lung disease
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Pericardial effusion (fluid around the heart)
- Platelet count decreased
- Pulmonary haemorrhage (acute bleeding from the lung)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- White blood cell count decreased
- Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)
male:
- Malaise (a feeling of general discomfort or uneasiness)
- Abdominal discomfort
- Myelosuppression (a decrease in the production of blood cells)
- Pleural effusion (water on the lungs)
- Tuberculous pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hepatic enzyme increased
What are the common drug interactions of Isoniazid and Sprycel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anaemia (lack of blood)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Headache (pain in head)
- Interstitial lung disease
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Oedema (fluid collection in tissue)
- Pericardial effusion (fluid around the heart)
- Platelet count decreased
- Pleural effusion (water on the lungs)
- Pulmonary haemorrhage (acute bleeding from the lung)
30-39:
n/a
40-49:
n/a
50-59:
- Pleural effusion (water on the lungs)
- Serum ferritin increased
- Colitis (inflammation of colon)
- Cryptococcosis (potentially fatal fungal disease)
- Dementia (madness)
- Folliculitis (infection of hair root)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haemoglobin decreased
- Headache (pain in head)
- Herpes zoster
60+:
- Myelosuppression (a decrease in the production of blood cells)
- Pleural effusion (water on the lungs)
- Tuberculous pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis)
- Haematemesis (vomiting of blood)
- Nausea (feeling of having an urge to vomit)
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 38.46%
- Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 4 people, 30.77%
- Gastric Ulcer (stomach ulcer): 4 people, 30.77%
- White Blood Cell Count Increased: 2 people, 15.38%
- Headache (pain in head): 2 people, 15.38%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 15.38%
- Tuberculous Pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis): 1 person, 7.69%
- Renal Cell Carcinoma (a kidney cancer): 1 person, 7.69%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Isoniazid and Sprycel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Isoniazid and Sprycel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Isoniazid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sprycel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Isoniazid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sprycel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .
- Ganguly, R. J., Abraham, R. R., Prasad, R., & Rao, B. C, "Hyperglycaemia induced by isoniazid preventive therapy", Journal of Family Medicine and Primary Care, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on isoniazid and dasatinib (the active ingredients of Isoniazid and Sprycel, respectively), and Isoniazid and Sprycel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atherosclerosis and Drug Intolerance - now
- Asthma and Postpartum Haemorrhage - 5 seconds ago
- Drug interactions of Atrovent Hfa and Norvir - 11 seconds ago
- Drug interactions of Buspar and Abilify - 27 seconds ago
- Could Rhinocort Allergy cause Malaise? - 30 seconds ago
- Could Gammagard cause Dyspnea Exacerbated? - 32 seconds ago
- Drug interactions of Arixtra and Rocephin - 33 seconds ago
- Could Zolpidem cause Neck Injury? - 34 seconds ago
- Could Femhrt cause Osteoporosis? - 41 seconds ago
- Could Acetaminophen cause Hepatic Trauma? - 41 seconds ago